William R Larue - Net Worth and Insider Trading
William R Larue Net Worth
The estimated net worth of William R Larue is at least $722 dollars as of 2024-05-05. William R Larue is the Director of TRACON Pharmaceuticals Inc and owns about 388 shares of TRACON Pharmaceuticals Inc (TCON) stock worth over $722. Details can be seen in William R Larue's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that William R Larue has not made any transactions after 2022-12-21 and currently still holds the listed stock(s).
Transaction Summary of William R Larue
William R Larue Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William R Larue owns 3 companies in total, including Oncternal Therapeutics Inc (ONCT) , TRACON Pharmaceuticals Inc (TCON) , and Histogen Inc (HSTO) .
Click here to see the complete history of William R Larue’s form 4 insider trades.
Insider Ownership Summary of William R Larue
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2019-06-07 | director |
| TCON | TRACON Pharmaceuticals Inc | 2022-12-21 | director |
| HSTO | Histogen Inc | 2017-02-06 | director |
William R Larue Latest Holdings Summary
William R Larue currently owns a total of 1 stock. William R Larue owns 388 shares of TRACON Pharmaceuticals Inc (TCON) as of December 21, 2022, with a value of $722.
Latest Holdings of William R Larue
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TCON | TRACON Pharmaceuticals Inc | 2022-12-21 | 388 | 1.86 | 722 |
Holding Weightings of William R Larue
William R Larue Form 4 Trading Tracker
According to the SEC Form 4 filings, William R Larue has made a total of 2 transactions in TRACON Pharmaceuticals Inc (TCON) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in TRACON Pharmaceuticals Inc is the sale of 6 shares on December 21, 2022, which brought William R Larue around $151.
Insider Trading History of William R Larue
- 1
William R Larue Trading Performance
GuruFocus tracks the stock performance after each of William R Larue's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William R Larue is -7.61%. GuruFocus also compares William R Larue's trading performance to market benchmark return within the same time period. The performance of stocks bought by William R Larue within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William R Larue's insider trading performs compared to the benchmark.
Performance of William R Larue
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.26 | | | | | |
| Relative Return to S&P 500(%) | -1.34 | | | | | |
William R Larue Ownership Network
William R Larue Owned Company Details
What does Oncternal Therapeutics Inc do?
Who are the key executives at Oncternal Therapeutics Inc?
William R Larue is the director of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Scientific Officer Gunnar F. Kaufmann , and Chief Medical Officer Salim Yazji .
Oncternal Therapeutics Inc (ONCT) Insider Trades Summary
Over the past 18 months, William R Larue made no insider transaction in Oncternal Therapeutics Inc (ONCT). Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , a net purchase of 150,000 shares made by James B Breitmeyer , and a net purchase of 30,000 shares made by Richard G Vincent .
In summary, during the past 3 months, insiders sold 980 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 10,980 shares, with a net purchase of 10,000 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 23,880 shares were bought by its insiders, resulting in a net purchase of 22,900 shares.
Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncternal Therapeutics Inc Insider Transactions
William R Larue Mailing Address
Above is the net worth, insider trading, and ownership report for William R Larue. You might contact William R Larue via mailing address: C/o Tracon Pharmaceuticals, Inc., 8910 University Center Lane, Suite 700, San Diego Ca 92122.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
